|
US5700466A
(en)
|
1981-09-08 |
1997-12-23 |
The Rockefeller University |
Method of ameliorating or preventing septic shock using a monoclonal antibody specific to cachectin/tumor necrosis factor
|
|
US6419927B1
(en)
|
1981-09-08 |
2002-07-16 |
Anthony Cerami |
Method for reducing adverse effects of a human 70kDa mediator which results from endotoxin stimulation of macrophages
|
|
US4603106A
(en)
|
1982-02-22 |
1986-07-29 |
The Rockefeller University |
Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
|
|
AU560087B2
(en)
|
1981-09-08 |
1987-03-26 |
Rockefeller University, The |
Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
|
|
US4822776A
(en)
|
1981-09-08 |
1989-04-18 |
The Rockefeller University |
Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
|
|
US6309640B1
(en)
|
1981-09-08 |
2001-10-30 |
The Rockefeller University |
Lipoprotein lipase suppression by endotoxin-induced mediator (shock assay)
|
|
US4816567A
(en)
|
1983-04-08 |
1989-03-28 |
Genentech, Inc. |
Recombinant immunoglobin preparations
|
|
JPS6147500A
(ja)
|
1984-08-15 |
1986-03-07 |
Res Dev Corp Of Japan |
キメラモノクロ−ナル抗体及びその製造法
|
|
JPS61100158A
(ja)
|
1984-10-22 |
1986-05-19 |
Fukuarare Honpo:Kk |
納豆付米菓の製造方法およびその製品
|
|
EP0212489B1
(en)
|
1985-08-16 |
1994-11-30 |
The Rockefeller University |
Anabolic activity modulator and uses thereof
|
|
US4870163A
(en)
|
1985-08-29 |
1989-09-26 |
New York Blood Center, Inc. |
Preparation of pure human tumor necrosis factor and hybridomas producing monoclonal antibodies to human tumor necrosis factor
|
|
DE3631229A1
(de)
|
1986-09-13 |
1988-03-24 |
Basf Ag |
Monoklonale antikoerper gegen humanen tumornekrosefaktor (tnf) und deren verwendung
|
|
EP0832981A1
(en)
|
1987-02-17 |
1998-04-01 |
Pharming B.V. |
DNA sequences to target proteins to the mammary gland for efficient secretion
|
|
JP2647427B2
(ja)
|
1987-04-24 |
1997-08-27 |
帝人株式会社 |
被検者の病態の判定のための検出方法、モノクロ−ナル抗体および検出キット
|
|
US4873316A
(en)
|
1987-06-23 |
1989-10-10 |
Biogen, Inc. |
Isolation of exogenous recombinant proteins from the milk of transgenic mammals
|
|
IL83878A
(en)
|
1987-09-13 |
1995-07-31 |
Yeda Res & Dev |
Soluble protein corresponding to tnf inhibitory protein its preparation and pharmaceutical compositions containing it
|
|
IL98078A0
(en)
|
1991-05-07 |
1992-06-21 |
Yeda Res & Dev |
Pharmaceutical compositions comprising an anticytokyne
|
|
GB8805792D0
(en)
|
1988-03-11 |
1988-04-13 |
Celltech Ltd |
Medicaments
|
|
DE3823804A1
(de)
|
1988-07-14 |
1990-01-18 |
Basf Ag |
Neutralisation der in vitro und in vivo toxischen eigenschaften von tnf-(alpha) durch monoklonale antikoerper und den davon abgeleiteten fragmenten
|
|
AU626572B2
(en)
|
1988-07-18 |
1992-08-06 |
Chiron Corporation |
Monoclonal antibodies reactive with cachectin
|
|
IL94039A
(en)
|
1989-08-06 |
2006-09-05 |
Yeda Res & Dev |
Antibodies to tbp - 1 and their use
|
|
US5360716A
(en)
|
1988-10-24 |
1994-11-01 |
Otsuka Pharmaceutical Co., Ltd. |
Human tumor necrosis factor αspecific monoclonal antibody and method for detecting human tumor necrosis factor α
|
|
JPH02227095A
(ja)
|
1988-10-24 |
1990-09-10 |
Otsuka Pharmaceut Co Ltd |
モノクローナル抗体
|
|
US5223395A
(en)
|
1988-12-01 |
1993-06-29 |
Centocor, Inc. |
Immunometric assays for tumor necrosis factor-alpha and methods for preventing the loss of biological activity of tumor necrosis factor-alpha in biological samples
|
|
US5342613A
(en)
|
1988-12-27 |
1994-08-30 |
Health Research Inc. |
Pharmaceutical compositions and use thereof in the treatment of psoriasis
|
|
PT92900A
(pt)
|
1989-01-24 |
1990-07-31 |
|
Sistema de vectores de expressao para a producao de anticorpos monoclonais quimericos
|
|
US4936843A
(en)
|
1989-02-16 |
1990-06-26 |
Ace Orthopedic Manufacturing |
Kirschner wire clamp and tensioner
|
|
DK0393438T3
(da)
|
1989-04-21 |
2005-05-30 |
Amgen Inc |
TNF-receptor, TNF-bindende proteiner og DNAér, der koder herfor
|
|
CA2017025C
(en)
|
1989-05-18 |
2008-07-22 |
David Wallach |
Tumor necrosis factor binding protein ii, its purification and antibodies thereto
|
|
US5959087A
(en)
|
1989-08-07 |
1999-09-28 |
Peptide Technology, Ltd. |
Tumour necrosis factor binding ligands
|
|
JP3443119B2
(ja)
|
1989-08-07 |
2003-09-02 |
ペプテック リミテッド |
腫瘍壊死因子結合リガンド
|
|
GB8921123D0
(en)
|
1989-09-19 |
1989-11-08 |
Millar Ann B |
Treatment of ards
|
|
DK0433900T3
(da)
|
1989-12-13 |
1996-01-29 |
Yeda Res & Dev |
Ekspression af rekombinant tumornekrosefaktor bindingsprotein I (TBP-I)
|
|
GB8928874D0
(en)
|
1989-12-21 |
1990-02-28 |
Celltech Ltd |
Humanised antibodies
|
|
DE4037604A1
(de)
|
1990-04-25 |
1991-10-31 |
Bayer Ag |
Verwendung von anti-tnf-antikoerpern als arzneimittel bei der behandlung von ischaemien und deren folgen
|
|
GB9014932D0
(en)
|
1990-07-05 |
1990-08-22 |
Celltech Ltd |
Recombinant dna product and method
|
|
GB9015908D0
(en)
|
1990-07-19 |
1990-09-05 |
Celltech Ltd |
Multivalent immunoglobulin
|
|
GB9022648D0
(en)
|
1990-10-18 |
1990-11-28 |
Charing Cross Sunley Research |
Polypeptide and its use
|
|
US5958413A
(en)
|
1990-11-01 |
1999-09-28 |
Celltech Limited |
Use of antibodies to TNF or fragments derived thereof and xanthine derivatives for combination therapy and compositions therefor
|
|
GB9109645D0
(en)
|
1991-05-03 |
1991-06-26 |
Celltech Ltd |
Recombinant antibodies
|
|
GB9028123D0
(en)
|
1990-12-28 |
1991-02-13 |
Erba Carlo Spa |
Monoclonal antibodies against human tumor necrosis factor alpha
|
|
SG63617A1
(en)
|
1991-01-18 |
1999-03-30 |
Amgen Boulder Inc |
Methods for treating tumar necrosis factor mediated diseases
|
|
US5656272A
(en)
|
1991-03-18 |
1997-08-12 |
New York University Medical Center |
Methods of treating TNF-α-mediated Crohn's disease using chimeric anti-TNF antibodies
|
|
DE69233701T2
(de)
|
1991-03-18 |
2008-04-10 |
New York University |
Monoklonale und chimäre Antikörper spezifisch für menschlichen Tumornekrosefaktor
|
|
US5919452A
(en)
|
1991-03-18 |
1999-07-06 |
New York University |
Methods of treating TNFα-mediated disease using chimeric anti-TNF antibodies
|
|
US7192584B2
(en)
|
1991-03-18 |
2007-03-20 |
Centocor, Inc. |
Methods of treating psoriasis with anti-TNF antibodies
|
|
US6277969B1
(en)
|
1991-03-18 |
2001-08-21 |
New York University |
Anti-TNF antibodies and peptides of human tumor necrosis factor
|
|
US6284471B1
(en)
|
1991-03-18 |
2001-09-04 |
New York University Medical Center |
Anti-TNFa antibodies and assays employing anti-TNFa antibodies
|
|
US5698195A
(en)
|
1991-03-18 |
1997-12-16 |
New York University Medical Center |
Methods of treating rheumatoid arthritis using chimeric anti-TNF antibodies
|
|
BR9206313A
(pt)
|
1991-07-25 |
1995-04-11 |
Idec Pharma Corp |
Anticorpos recombinantes para terapia humana.
|
|
MX9204374A
(es)
|
1991-07-25 |
1993-03-01 |
Idec Pharma Corp |
Anticuerpo recombinante y metodo para su produccion.
|
|
EP0525570A3
(en)
|
1991-07-31 |
1993-10-06 |
Miles Inc. |
Anti-idiotypic antibodies that mimic tnf
|
|
IL99120A0
(en)
|
1991-08-07 |
1992-07-15 |
Yeda Res & Dev |
Multimers of the soluble forms of tnf receptors,their preparation and pharmaceutical compositions containing them
|
|
NO178839C
(no)
|
1991-11-25 |
1996-06-12 |
Ottestad Nils T |
Strömningsregulator for opprettholdelse av en stabil strömningsmengde av et fluidum
|
|
ATE408012T1
(de)
|
1991-12-02 |
2008-09-15 |
Medical Res Council |
Herstellung von autoantikörpern auf phagenoberflächen ausgehend von antikörpersegmentbibliotheken
|
|
DE69321909T2
(de)
|
1992-08-28 |
1999-04-01 |
Bayer Corp., Pittsburgh, Pa. |
Verwendung von monoklonalen Anti-TNF-Antikörpern für die Behandlung von bakteriellen Meningitiden
|
|
JP3616091B2
(ja)
|
1992-10-08 |
2005-02-02 |
ザ ケネディー インスティチュート オブ リューマトロジー |
自己免疫疾患および炎症性疾患の治療
|
|
AU682156B2
(en)
|
1992-10-15 |
1997-09-25 |
Dana-Farber Cancer Institute, Inc. |
Treatment of insulin resistance in obesity linked type II diabetes using antagonists to TNF-alpha function
|
|
GB9225448D0
(en)
|
1992-12-04 |
1993-01-27 |
Erba Carlo Spa |
Improved synthesis of polymer bioactive conjugates
|
|
US5888511A
(en)
|
1993-02-26 |
1999-03-30 |
Advanced Biotherapy Concepts, Inc. |
Treatment of autoimmune diseases, including AIDS
|
|
DK0614984T4
(da)
|
1993-03-05 |
2010-12-20 |
Bayer Healthcare Llc |
Humane monoklonale anti-TNF-alfa-antistoffer
|
|
SE9302490D0
(sv)
|
1993-07-26 |
1993-07-26 |
Kabi Pharmacia Ab |
New use of old drugs
|
|
US5827690A
(en)
|
1993-12-20 |
1998-10-27 |
Genzyme Transgenics Corporatiion |
Transgenic production of antibodies in milk
|
|
GB9403909D0
(en)
|
1994-03-01 |
1994-04-20 |
Erba Carlo Spa |
Ureido derivatives of naphthalenephosphonic acids and process for their preparation
|
|
US6190691B1
(en)
|
1994-04-12 |
2001-02-20 |
Adolor Corporation |
Methods for treating inflammatory conditions
|
|
FR2728793A1
(fr)
|
1994-12-28 |
1996-07-05 |
Oreal |
Utilisation d'un antagoniste d'histamine, d'un antagoniste d'interleukine 1 et/ou d'un antagoniste de tnf-alpha dans une composition cosmetique, pharmaceutique ou dermatologique et composition obtenue
|
|
JP4312259B2
(ja)
|
1995-04-27 |
2009-08-12 |
アムジェン フレモント インク． |
免疫したゼノマウス（ＸｅｎｏＭｏｕｓｅ）に由来するヒト抗体
|
|
DE69721548T2
(de)
|
1996-02-09 |
2004-04-01 |
Abbott Laboratories(Bermuda)Ltd. |
HUMANE ANTIKÖRPER WELCHE AN HUMANEN TNFalpha BINDEN
|
|
GB9702088D0
(en)
|
1997-01-31 |
1997-03-19 |
Pharmacia & Upjohn Spa |
Matrix metalloproteinase inhibitors
|
|
JPH11127855A
(ja)
|
1997-10-27 |
1999-05-18 |
Japan Energy Corp |
組換え型抗ヒトＴＮＦ−αヒトモノクローナル抗体
|
|
UA81743C2
(uk)
|
2000-08-07 |
2008-02-11 |
Центокор, Инк. |
МОНОКЛОНАЛЬНЕ АНТИТІЛО ЛЮДИНИ, ЩО СПЕЦИФІЧНО ЗВ'ЯЗУЄТЬСЯ З ФАКТОРОМ НЕКРОЗУ ПУХЛИН АЛЬФА (ФНПα), ФАРМАЦЕВТИЧНА КОМПОЗИЦІЯ, ЩО ЙОГО МІСТИТЬ, ТА СПОСІБ ЛІКУВАННЯ РЕВМАТОЇДНОГО АРТРИТУ
|
|
TWI334439B
(en)
|
2001-08-01 |
2010-12-11 |
Centocor Inc |
Anti-tnf antibodies, compositions, methods and uses
|
|
AU2003225976A1
(en)
|
2002-03-26 |
2003-10-13 |
Centocor, Inc. |
Anti-tnf antibodies, compositions, methods and uses
|
|
CN101745112A
(zh)
*
|
2002-07-19 |
2010-06-23 |
艾博特生物技术有限公司 |
TNFα相关疾病的治疗
|
|
TW201705980A
(zh)
*
|
2004-04-09 |
2017-02-16 |
艾伯維生物技術有限責任公司 |
用於治療ＴＮＦα相關失調症之多重可變劑量療法
|
|
CN103254309B
(zh)
*
|
2005-05-18 |
2017-09-26 |
埃博灵克斯股份有限公司 |
针对肿瘤坏死因子α的改进的纳米体TM
|
|
KR20080048505A
(ko)
*
|
2005-08-31 |
2008-06-02 |
센토코 인코포레이티드 |
증진된 작용자 기능을 지닌 항체 불변 영역을 생산하기위한 숙주 세포주
|
|
WO2011017294A1
(en)
*
|
2009-08-07 |
2011-02-10 |
Schering Corporation |
Human anti-rankl antibodies
|
|
WO2012050907A2
(en)
*
|
2010-09-28 |
2012-04-19 |
The Regents Of The University Of California |
Gaba agonists in the treatment of disorders associated with metabolic syndrome and gaba combinations in treatment or prophylaxis of type i diabetes
|
|
EP2964669B1
(en)
*
|
2013-03-06 |
2018-09-12 |
Protalix Ltd. |
Use of plant cells expressing a tnfalpha polypeptide inhibitor in therapy
|